Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329 | ISIN: INE0H5O01029 | Industry: Pharmaceuticals
| Slowing Down Stock
884.4000 5.45 (0.62%)
NSE Jun 20, 2025 15:31 PM
Volume: 24,509
 

884.40
0.62%
ICICI Securities Limited
Leading player in fast growing CDMO market With increasing globalisation and focus of large pharmaceutical players on cutting costs and optimising operations, CDMOs have seen significant acceptance in the pharmaceutical industry internationally over the last few years. The domestic formulations CDMO market has grown at a higher rate of ~13% compared to ~8.6% growth of the domestic formulations market (in terms of consumption) in the past five years. The company believe this increasing use of outsourcing by pharmaceutical companies for launch of...
Windlas Biotech Ltd. is trading below all available SMAs
More from Windlas Biotech Ltd.
Recommended